lysergol has been researched along with ergoline in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 11 (47.83) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Eich, E; Pertz, H | 1 |
| Augé, C; Fiserová, A; Havlícek, V; Kren, V; Sedmera, P; Síma, P | 1 |
| Izzarelli, DG; Lewis-Higgins, L; Palmer, D; Parker, EM; Shapiro, RA | 1 |
| Eich, E; Milhahn, H; Pertz, HH | 1 |
| Brown, AM; Gager, TL; Kaumann, AJ; Pertz, HH | 1 |
| Berseneva, EA; Smirnov, VM; Sveshnikov, DS | 1 |
| Dawe, DL; Hiatt, EE; Hill, NS; Ju, HJ; Rottinghaus, GW; Stuedemann, JA; Thompson, FN | 1 |
| Bush, L; Craig, M; Fannin, N; Lehner, AF; Tobin, T | 1 |
| Craig, AM; Fleischmann, T; Lodge-Ivey, SL; True, JE; Walker, K | 1 |
| Fujii, N; Inuki, S; Ohno, H; Oishi, S | 1 |
| Deck, JA; Martin, SF | 1 |
| Fujii, N; Inuki, S; Iwata, A; Ohno, H; Oishi, S | 1 |
| Fletcher, L; Gooneratne, SR; Scannell, M; Wellby, M | 1 |
| Maurya, A; Srivastava, SK; Verma, RK | 1 |
| Anandjiwala, S; Dash, RP; Nivsarkar, M; Patil, S | 1 |
| Kuchuk, AV; Myasnikov, IL; Smirnov, VM; Sveshnikov, DS | 1 |
| Darokar, MP; Dwivedi, GR; Maurya, A; Srivastava, SK | 1 |
| Alexander, A; Kumari, L; Qureshi, A; Saraf, S; Sharma, M; Vaishnav, P | 1 |
| Kremer, C; Paulke, A; Schubert-Zsilavecz, M; Toennes, SW; Wunder, C; Wurglics, M | 1 |
| Guo, Z; Luo, T; Yuan, H | 1 |
| Bhunia, S; Bisai, A; Chaudhuri, S | 1 |
| Tasker, NR; Wipf, P | 1 |
| Lu, JT; Wang, J; Yue, X; Zong, Y | 1 |
1 review(s) available for lysergol and ergoline
| Article | Year |
|---|---|
Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients.
Topics: Adjuvants, Pharmaceutic; Alkaloids; Benzodioxoles; Biological Availability; Carum; Cuminum; Curcumin; Ergolines; Flavanones; Genistein; Glycyrrhizic Acid; Humans; Morphinans; Piperidines; Plant Extracts; Polyunsaturated Alkamides; Quercetin; Zingiber officinale | 2014 |
22 other study(ies) available for lysergol and ergoline
| Article | Year |
|---|---|
O-acylated lysergol and dihydrolysergol-I derivatives as competitive antagonists of 5-HT at 5-HT2 receptors of rat tail artery. Allosteric modulation instead of pseudoirreversible inhibition.
Topics: Animals; Binding, Competitive; Ergolines; In Vitro Techniques; Lysergic Acid; Male; Methysergide; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Regional Blood Flow; Serotonin Antagonists; Tail | 1992 |
Ergot alkaloid glycosides with immunomodulatory activities.
Topics: Adjuvants, Immunologic; Animals; Carbohydrate Sequence; Cells, Cultured; Cytotoxicity, Immunologic; Ergolines; Ergot Alkaloids; Glycosides; Humans; Killer Cells, Natural; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Rats; Spectrometry, Mass, Fast Atom Bombardment; Tumor Cells, Cultured | 1996 |
Two amino acid differences in the sixth transmembrane domain are partially responsible for the pharmacological differences between the 5-HT1D beta and 5-HT1E 5-hydroxytryptamine receptors.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Binding, Competitive; Chlorocebus aethiops; Cloning, Molecular; COS Cells; DNA Primers; Ergolines; Glutamic Acid; Humans; Isoleucine; Kinetics; Ligands; Lysine; Models, Structural; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Protein Structure, Secondary; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Serine; Serotonin; Transfection | 1996 |
Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high
Topics: Animals; Aorta, Thoracic; Arteries; Ergolines; Female; Guinea Pigs; Iliac Artery; In Vitro Techniques; Lysergic Acid; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tail | 1999 |
Simple O-acylated derivatives of lysergol and dihydrolysergol-I: synthesis and interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha1 adrenergic receptors.
Topics: Animals; Antipsychotic Agents; Arteries; Binding, Competitive; Ergolines; In Vitro Techniques; Inositol Phosphates; Male; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship | 1999 |
[Potential role of serotonin-sensitive structures in amplification of duodenal motor activity due to irritation of sympathetic trunk].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Fibers; Animals; Dogs; Duodenum; Ergolines; Female; Gastrointestinal Motility; Male; Muscle, Smooth; Phentolamine; Physical Stimulation; Pressure; Propranolol; Receptors, Adrenergic; Receptors, Serotonin; Serotonin Antagonists; Stimulation, Chemical | 1999 |
Ergot alkaloid transport across ruminant gastric tissues.
Topics: Animals; Biological Transport; Ergolines; Ergonovine; Ergot Alkaloids; Ergotamine; Female; Intestinal Absorption; Linear Models; Lysergic Acid; Omasum; Random Allocation; Reticulum; Rumen; Sheep; Sodium Azide | 2001 |
Fragmentation patterns of selected ergot alkaloids by electrospray ionization tandem quadrupole mass spectrometry.
Topics: Animal Feed; Animals; Ergolines; Ergonovine; Ergot Alkaloids; Ergotamine; Ergotamines; Festuca; Food Contamination; Horse Diseases; Horses; Lysergic Acid; Spectrometry, Mass, Electrospray Ionization | 2004 |
Detection of lysergic acid in ruminal fluid, urine, and in endophyte-infected tall fescue using high-performance liquid chromatography.
Topics: Animals; Cattle; Chromatography, High Pressure Liquid; Ergolines; Ergotamines; Lysergic Acid; Male; Molecular Structure; Poaceae; Rumen | 2006 |
Total synthesis of (+/-)-lysergic acid, lysergol, and isolysergol by palladium-catalyzed domino cyclization of amino allenes bearing a bromoindolyl group.
Topics: Alkadienes; Bromine; Catalysis; Cyclization; Ergolines; Indoles; Lysergic Acid; Palladium; Stereoisomerism | 2008 |
Enantioselective synthesis of (+)-isolysergol via ring-closing metathesis.
Topics: Catalysis; Cyclization; Ergolines; Microwaves; Molecular Structure; Molybdenum; Stereoisomerism | 2010 |
Enantioselective total synthesis of (+)-lysergic acid, (+)-lysergol, and (+)-isolysergol by palladium-catalyzed domino cyclization of allenes bearing amino and bromoindolyl groups.
Topics: Catalysis; Cyclization; Ergolines; Ergot Alkaloids; Indoles; Lysergic Acid; Magnetic Resonance Spectroscopy; Molecular Structure; Palladium; Stereoisomerism | 2011 |
Changes in concentrations of lysergol in urine and prolactin in plasma, rectal temperature and respiration rate in sheep selected for resistance or susceptibility to ryegrass staggers and fed ergovaline.
Topics: Analysis of Variance; Animal Feed; Animals; Body Temperature; Ergolines; Ergotamines; Lolium; Mycotoxicosis; Mycotoxins; Plants, Toxic; Prolactin; Respiratory Rate; Sheep | 2011 |
Quantitative determination of bioactive alkaloids lysergol and chanoclavine in Ipomoea muricata by reversed-phase high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Ergolines; Ipomoea; Least-Squares Analysis; Reproducibility of Results; Seeds; Sensitivity and Specificity | 2012 |
Simultaneous quantification of berberine and lysergol by HPLC-UV: evidence that lysergol enhances the oral bioavailability of berberine in rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Berberine; Biological Availability; Chromatography, High Pressure Liquid; Drug Stability; Drug Synergism; Ergolines; Linear Models; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2012 |
Study of the nature of sympathetic trunk nerve fibers enhancing gastric motility.
Topics: Adrenergic Antagonists; Adrenergic Fibers; Animals; Dogs; Electric Stimulation; Ergolines; Gastrointestinal Motility; Phentolamine; Propranolol; Serotonergic Neurons | 2012 |
Antibacterial and synergy of clavine alkaloid lysergol and its derivatives against nalidixic acid-resistant Escherichia coli.
Topics: Adenosine Triphosphatases; Anti-Bacterial Agents; Anti-Infective Agents; ATP-Binding Cassette Transporters; Drug Resistance, Bacterial; Drug Synergism; Ergolines; Ergot Alkaloids; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline | 2013 |
Identification of legal highs--ergot alkaloid patterns in two Argyreia nervosa products.
Topics: Alkaloids; Chromatography, Liquid; Convolvulus; Ergolines; Ergonovine; Humans; Indoles; Lysergic Acid Diethylamide; Molecular Structure; Psychotropic Drugs; Seeds; Tandem Mass Spectrometry | 2014 |
Synthesis of (+)-Lysergol and Its Analogues To Assess Serotonin Receptor Activity.
Topics: Ergolines; Molecular Structure; Receptors, Serotonin | 2017 |
Total Syntheses of Pyroclavine, Festuclavine, Lysergol, and Isolysergol via a Catalytic Asymmetric Nitro-Michael Reaction.
Topics: Catalysis; Cyclization; Ergolines; Ergot Alkaloids; Nitroso Compounds; Proline; Stereoisomerism | 2017 |
A Short Synthesis of
Topics: Alkenes; Dopamine Agonists; Ergolines; Ergot Alkaloids; Esters; Hydrogen; Serotonin | 2022 |
Total Synthesis of (+)-Isolysergol.
Topics: Catalysis; Cyclization; Ergolines; Molecular Structure | 2023 |